Engineered Transition Metal Oxide (TMO)-Encapsulated Salmon Skin-Based Bioadhesive Hydrogel Promotes Repair, Immuneregulation, and Neovascularization in MRSA-Infected Wounds
Source abstract
Abstract
Despite success in promoting tissue regeneration, the abundant nutrients in the decellularized extracellular matrix (dECM) are easily prone to environmental bacteria in vitro . Additionally, these dECM-based materials suffer from weak mechanical strength and rapid biodegradation, significantly limiting their potential for wound healing applications. To overcome these aspects, an innovative biohydrogel platform based on transition metal oxides (TMOs)-encapsulated salmon fish skin-derived dECM (FdECM) was developed to promote subsequent antibacterial activity and wound healing. The decellularization-assisted FdECM was initially grafted with photoresponsive methacrylic anhydride (MA) groups through amidation and then encapsulated with silver (Ag) nanodots-decorated manganese dioxide (MnO 2 ) nanoflowers (ζ value of −20 mV and size of 300 nm) to form FdECM-MA-Ag-MnO 2 (shortly denoted as Fd-AM) composites. Meanwhile, the Fd-AM demonstrated excellent adhesion, biocompatibility, and improved mechanical properties. FdECM and Ag-MnO 2 nanoparticles work synergistically to effectively reduce oxidative stress in cells and promote the formation of tube-like structures by endothelial cells. Both in vitro and in vivo studies showed that the degradation of biocompatible Fd-AM biohydrogel released Ag-MnO 2, improving the hypoxic environment via MnO 2 and significantly combating methicillin-resistant Staphylococcus aureus (MRSA) through silver nanodots. The Fd-AM biohydrogel promoted the effective transformation of macrophages into M2 type, as evidenced by increased IL-10, decreased IL-6, higher CD206 (an M2 macrophage marker), and lower iNOS (an M1 macrophage marker). Additionally, these composites enhanced collagen deposition, exhibited antioxidant properties, and increased CD31 content. Overall, the TMO-encapsulated Fd-AM biohydrogel successfully delivered both antibacterial and antioxidant effects, supporting tissue regeneration (angiogenesis) in MRSA-infected wounds.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Electrospun Nanofibers in Biomedical Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Biomaterials and Tissue Engineering
Huaqiao University
College of Chemical Engineering
Fujian Provincial Key Laboratory of Biochemical Technology
(Huaqiao University)
Funding
Fujian Provincial Department of Science and Technology · Ministry of Science and Technology of the People's Republic of China · Natural Science Foundation of Fujian Province · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China
References (70)
Show source-provided references
1. 10.1089/wound.2021.002610.1089/wound.2021.0026 ↗
2. 10.1089/wound.2015.063510.1089/wound.2015.0635 ↗
3. 10.1038/nature1203410.1038/nature12034 ↗
4. 10.1002/advs.20190051310.1002/advs.201900513 ↗
5. 10.1126/scitranslmed.300933710.1126/scitranslmed.3009337 ↗
6. 10.1016/j.jgar.2021.05.01010.1016/j.jgar.2021.05.010 ↗
7. 10.1016/j.ijbiomac.2019.10.00910.1016/j.ijbiomac.2019.10.009 ↗
8. 10.1002/smll.20170013010.1002/smll.201700130 ↗
9. 10.1021/acsnano.0c0628710.1021/acsnano.0c06287 ↗
10. 10.1016/j.actbio.2023.10.02810.1016/j.actbio.2023.10.028 ↗
11. 10.1016/j.bioactmat.2021.07.00510.1016/j.bioactmat.2021.07.005 ↗
12. 10.1016/j.biomaterials.2005.05.05810.1016/j.biomaterials.2005.05.058 ↗
13. 10.1021/acsbiomaterials.7b0091310.1021/acsbiomaterials.7b00913 ↗
14. 10.1016/j.ijbiomac.2023.12451010.1016/j.ijbiomac.2023.124510 ↗
15. 10.1016/j.biomaterials.2016.02.00310.1016/j.biomaterials.2016.02.003 ↗
16. 10.1016/j.mtbio.2023.10058910.1016/j.mtbio.2023.100589 ↗
17. 10.1016/j.compositesb.2022.11043710.1016/j.compositesb.2022.110437 ↗
18. 10.1093/rb/rbad10710.1093/rb/rbad107 ↗
19. 10.1016/j.actbio.2016.11.06810.1016/j.actbio.2016.11.068 ↗
20. 10.1016/j.ijbiomac.2024.13783110.1016/j.ijbiomac.2024.137831 ↗
21. 10.1016/j.eng.2022.05.02210.1016/j.eng.2022.05.022 ↗
22. 10.1016/j.cej.2025.16227010.1016/j.cej.2025.162270 ↗
23. 10.1063/5.018548410.1063/5.0185484 ↗
24. 10.1021/acs.biomac.3c0025310.1021/acs.biomac.3c00253 ↗
25. 10.1002/adma.20120529210.1002/adma.201205292 ↗
26. 10.1021/ja307589n10.1021/ja307589n ↗
27. 10.1186/s12951-022-01315-x10.1186/s12951-022-01315-x ↗
28. 10.1002/adma.20190703510.1002/adma.201907035 ↗
29. 10.1016/j.addr.2022.11427010.1016/j.addr.2022.114270 ↗
30. 10.1016/j.clay.2015.04.01810.1016/j.clay.2015.04.018 ↗
31. 10.1016/j.addr.2006.09.01110.1016/j.addr.2006.09.011 ↗
32. 10.1002/anie.20080258510.1002/anie.200802585 ↗
33. 10.1016/j.ccr.2022.21454010.1016/j.ccr.2022.214540 ↗
34. 10.1002/adfm.20170637510.1002/adfm.201706375 ↗
35. 10.1002/adfm.20230599210.1002/adfm.202305992 ↗
36. 10.1016/j.ijbiomac.2025.14327110.1016/j.ijbiomac.2025.143271 ↗
37. 10.1021/acs.molpharmaceut.4c0089610.1021/acs.molpharmaceut.4c00896 ↗
38. 10.1021/acsmaterialslett.3c0161510.1021/acsmaterialslett.3c01615 ↗
39. 10.1002/adhm.20230358210.1002/adhm.202303582 ↗
40. 10.1021/acsmaterialslett.3c0107010.1021/acsmaterialslett.3c01070 ↗
41. 10.1016/j.carbon.2021.03.06510.1016/j.carbon.2021.03.065 ↗
42. 10.1016/j.biomaterials.2020.12031410.1016/j.biomaterials.2020.120314 ↗
43. 10.1021/acsnano.9b0759810.1021/acsnano.9b07598 ↗
44. 10.1016/j.biopha.2023.11464310.1016/j.biopha.2023.114643 ↗
45. 10.1016/j.ijbiomac.2022.09.17210.1016/j.ijbiomac.2022.09.172 ↗
46. 10.1016/j.biomaterials.2011.01.05710.1016/j.biomaterials.2011.01.057 ↗
47. 10.1016/j.bioadv.2024.21385010.1016/j.bioadv.2024.213850 ↗
48. 10.1021/acsabm.1c0108710.1021/acsabm.1c01087 ↗
49. 10.1021/acs.biomac.7b0122110.1021/acs.biomac.7b01221 ↗
50. 10.1016/j.jmbbm.2017.03.03010.1016/j.jmbbm.2017.03.030 ↗
51. 10.1002/adfm.20200051110.1002/adfm.202000511 ↗
52. 10.1002/smll.20200058910.1002/smll.202000589 ↗
53. 10.1002/adfm.20210104010.1002/adfm.202101040 ↗
54. 10.1021/acsbiomaterials.4c0242010.1021/acsbiomaterials.4c02420 ↗
55. 10.1002/term.242210.1002/term.2422 ↗
56. Miwa, S.; Kashyap, S.; Chini, E.; von Zglinicki, T.Mitochondrial dysfunction in cell senescence and aging J. Clin. Invest. 2022; Vol. 132 1310.1172/JCI158447.10.1172/JCI158447 ↗
57. 10.1002/adhm.20230256610.1002/adhm.202302566 ↗
58. 10.1111/wrr.1238110.1111/wrr.12381 ↗
59. 10.1186/s12951-023-01929-910.1186/s12951-023-01929-9 ↗
60. 10.1111/imm.1274110.1111/imm.12741 ↗
61. 10.1016/j.actbio.2023.05.02710.1016/j.actbio.2023.05.027 ↗
62. 10.1016/j.bioactmat.2023.10.00710.1016/j.bioactmat.2023.10.007 ↗
63. 10.1016/j.biomaterials.2020.12039010.1016/j.biomaterials.2020.120390 ↗
64. 10.1021/acsnano.2c0378110.1021/acsnano.2c03781 ↗
65. 10.1002/smll.20230349410.1002/smll.202303494 ↗
66. 10.1016/j.cej.2024.14976110.1016/j.cej.2024.149761 ↗
67. 10.1002/adhm.20250021910.1002/adhm.202500219 ↗
68. 10.1016/j.cej.2020.12758910.1016/j.cej.2020.127589 ↗
69. 10.1002/adhm.20240453510.1002/adhm.202404535 ↗
70. 10.1016/j.apsusc.2021.15079710.1016/j.apsusc.2021.150797 ↗